Next Article in Journal
Quantification of the Anticoagulatory Effect of Novel Anticoagulants and Management of Emergencies
Previous Article in Journal
Research Prize 2012 of the Swiss Heart Foundation
 
 
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Dawn of a New Era of Oral Anticoagulation

Cardiac Arrhythmia Unit, Department of Cardiology, University Hospital, CH-8091 Zurich, Switzerland
Cardiovasc. Med. 2012, 15(5), 143; https://doi.org/10.4414/cvm.2012.01669
Submission received: 16 February 2012 / Revised: 16 March 2012 / Accepted: 16 April 2012 / Published: 16 May 2012

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Ever since their introduction in the middle of the 20th century, vitamin K antagonists (VKAs) have been used in the treatment and prevention of thromboembolic diseases, especially for venous thromboembolism and stroke prevention in atrial fibrillation (AF) [...]

Share and Cite

MDPI and ACS Style

Steffel, J. Dawn of a New Era of Oral Anticoagulation. Cardiovasc. Med. 2012, 15, 143. https://doi.org/10.4414/cvm.2012.01669

AMA Style

Steffel J. Dawn of a New Era of Oral Anticoagulation. Cardiovascular Medicine. 2012; 15(5):143. https://doi.org/10.4414/cvm.2012.01669

Chicago/Turabian Style

Steffel, Jan. 2012. "Dawn of a New Era of Oral Anticoagulation" Cardiovascular Medicine 15, no. 5: 143. https://doi.org/10.4414/cvm.2012.01669

APA Style

Steffel, J. (2012). Dawn of a New Era of Oral Anticoagulation. Cardiovascular Medicine, 15(5), 143. https://doi.org/10.4414/cvm.2012.01669

Article Metrics

Back to TopTop